HUMAN GLANDULAR KALLIKREIN 2: A POTENTIAL SERUM MARKER FOR PREDICTING THE ORGAN CONFINED VERSUS NONORGAN CONFINED GROWTH OF PROSTATE CANCER-Reference-Cited by-同舟云学术

HUMAN GLANDULAR KALLIKREIN 2: A POTENTIAL SERUM MARKER FOR PREDICTING THE ORGAN CONFINED VERSUS NONORGAN CONFINED GROWTH OF PROSTATE CANCER

Published:2000-05 Issue:5 Volume:163 Page:1491-1497
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

HAESE ALEXANDER¹,BECKER CHARLOTTE¹,NOLDUS JOACHIM¹,GRAEFEN MARKUS¹,HULAND EDITH¹,HULAND HARTWIG¹,LILJA HANS¹

Affiliation:

1. From the Department of Urology, University Clinic Eppendorf, Hamburg, Germany, and Department of Clinical Chemistry, Lund University, Malmö, Sweden

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference39 articles.

1. Some physio-chemical characteristics of “gamma-seminoprotein,” an antigenic component specific for human seminal plasma. Forensic immunological study of body fluids and secretion;Hara;Jpn J Legal Med,1971

2. Purification of a human prostate specific antigen;Wang;Invest Urol,1979

3. Measurement of prostate specific antigen in serum as a screening test for prostate cancer;Catalona;New Engl J Med,1991

4. Prostate specific antigen: a critical assessment of the most useful tumor marker for adenocarcinoma of the prostate;Oesterling;J Urol,1991

Cited by 68 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Activation of GPR56, a novel adhesion GPCR, is necessary for nuclear androgen receptor signaling in prostate cells;PLOS ONE;2020-09-03

2. A pre-specified model based on four kallikrein markers in blood improves predictions of adverse pathology and biochemical recurrence after radical prostatectomy;British Journal of Cancer;2020-05-29

3. Activation of GPR56, a novel adhesion GPCR, is necessary for nuclear androgen receptor signaling in prostate cells;2019-11-21

4. Discovery of novel transcripts of the human tissue kallikrein (KLK1) and kallikrein-related peptidase 2 (KLK2) in human cancer cells, exploiting Next-Generation Sequencing technology;Genomics;2019-07

5. “Mix-to-Go” Silver Colloidal Strategy for Prostate Cancer Molecular Profiling and Risk Prediction;Analytical Chemistry;2018-09-27